Search results for "Sulfanilamide"

showing 10 items of 16 documents

Comparison of high-pressure liquid chromatography (HPLC) and Griess reagent-spectroscopic methods for the measurement of nitrate in serum from health…

2008

Bioavailability of NO can be estimated by measuring the concentration of nitrate (NO(3)) in serum. However, the methods used for the measurement NO(3) in plasma or serum show a great degree of variation. Therefore, we compared two analytical methods for the measurement of NO(3) in serum.The concentration of NO(3) in 600 serum samples collected from healthy individuals was determined by the HPLC and by the Griess reagent-spectroscopic method.The concentration of NO(3) in the samples was 29.4+/-16.1 micromol/L and 26.2+/-14.0 micromol/L (mean+/-SD) measured by HPLC and Griess reagent-spectroscopic method respectively (p0.0001). We detected a significant correlation between the two methods (R=…

Adultinorganic chemicalsAdolescentClinical BiochemistryHigh-performance liquid chromatographyYoung Adultchemistry.chemical_compoundNitrateGriess testSulfanilamidesHumansHplc methodReference standardsChromatography High Pressure LiquidAgedAged 80 and overNitratesChromatographySpectrum Analysisorganic chemicalsfood and beveragesGeneral MedicineMiddle AgedReference StandardsEthylenediaminesSerum samplesBioavailabilitychemistryHealthy individualsClinical Biochemistry
researchProduct

Synthesis, Characterization, Thermal and Antimicrobial studies of N-substituted Sulfanilamide derivatives

2014

Abstract Four sulfanilamide derivatives N -[4-(phenylsulfamoyl)phenyl]acetamide (1), 4-amino- N -phenylbenzenesulfonamide (2), N -[4-(phenylsulfamoyl)phenyl]benzamide (3) and N -{4-[(3-chlorophenyl)sulfamoyl]phenylbenzamide (4) were synthesized and characterized by Infra-Red (IR), Nuclear Magnetic Resonance (NMR) and UV–visible (UV–Vis) spectra. Also Liquid Chromatographic (LCMS) and High Resolution Mass Spectrometric (HRMS) methods were used. Crystal structures of 1–4 were determined by single crystal X-ray diffraction (XRD) and their conformational and hydrogen bond (HB) network properties were examined with survey of the literature data. Compounds 1 and 2 crystallize in the same orthorho…

CARBONIC-ANHYDRASE INHIBITORSStereochemistryCrystal structureAntimicrobial activitySOLUBILITYTriclinic crystal systemAnalytical ChemistryInorganic ChemistrySynthesischemistry.chemical_compoundDESIGNSulfanilamidesmedicineSUBLIMATIONCRYSTAL-STRUCTUREThermal analysista116SpectroscopySULFONAMIDE DERIVATIVESHydrogen bondCrystal structureOrganic ChemistryThermal decompositionSulfanilamideX-ray diffractionCrystallographySOLVATIONchemistryACIDOrthorhombic crystal systemAcetamidemedicine.drugMonoclinic crystal systemJournal of Molecular Structure
researchProduct

R plasmids in environmental Vibrio cholerae non-O1 strains.

1988

The occurrence of drug resistance and its plasmid-mediated transferability was investigated in 140 environmental strains of Vibrio cholerae non-O1 and 6 strains of Vibrio cholerae, both O1 and non-O1, of clinical origin. Of the 146 strains tested, 93% were resistant to at least one drug and 74% were resistant to two or more antibiotics. The O1 strains were susceptible to all antibiotics used. A total of 26 of 28 selected resistant wild strains carried R plasmids that were transferable by intraspecific and intergeneric matings. The most common transmissible R factor determined resistance to ampicillin, amoxicillin, and sulfanilamide (30%), followed by resistance to ampicillin and amoxicillin…

DNA BacterialR FactorsFresh WaterDrug resistancemedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiologyPlasmidVibrio cholerae non-O1VibrionaceaeAmpicillinmedicineSeawaterVibrio choleraeElectrophoresis Agar GelEcologybiologyVirulenceGenetic transferDrug Resistance MicrobialSulfanilamidebiology.organism_classificationAnti-Bacterial AgentsVibrio choleraeConjugation GeneticWater MicrobiologyFood ScienceBiotechnologymedicine.drugResearch Article
researchProduct

Microtubule distribution in gravitropic protonemata of the mossCeratodon

1990

Tip cells of dark-grown protonemata of the moss Ceratodon purpureus are negatively gravitropic (grow upward). They possess a unique longitudinal zonation: (1) a tip group of amylochloroplasts in the apical dome, (2) a plastid-free zone, (3) a zone of significant plastid sedimentation, and (4) a zone of mostly non-sedimenting plastids. Immunofluorescence of vertical cells showed microtubules distributed throughout the cytoplasm in a mostly axial orientation extending through all zones. Optical sectioning revealed a close spatial association between microtubules and plastids. A majority (two thirds) of protonemata gravistimulated for > 20 min had a higher density of microtubules near the lowe…

GravitropismPlant DevelopmentPlant ScienceBiologyMicrotubulesGravitropismchemistry.chemical_compoundMicrotubulePlant CellsSulfanilamidesBotanyPlastidsTip growthPlastidProtonemaNitrobenzenesCeratodon purpureusHerbicidesfungifood and beveragesOrganothiophosphorus CompoundsCell BiologyGeneral MedicineDarknessPlantsOryzalinbiology.organism_classificationCell CompartmentationDinitrobenzeneschemistryCytoplasmMicrotubule ProteinsBiophysicsGravitationProtoplasma
researchProduct

Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells

2014

Novel sulfa Schiff bases were synthesized and characterized by a reaction between aromatic sulfonamides and aromatic aldehydes or heterocyclic ketones in equimolar ratios. Their cytotoxicity was evaluated by the resazurin assay towards human sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells. Three of the tested compounds viz., 4-(anthracen-9-ylmethyleneamino)-N-(pyrimidin-2-yl)benzenesulfonamide (4), 4-(anthracen-9- ylmethyleneamino)benzenesulfonamide, (5) and 4-((3-phenylallylidene)amino)benzene-sulfonamide, (6) were cytotoxic (IC 50 values: 5.38-19.96 µM). CEM/ADR5000 cells were not cross-resistant to these compounds, indicating activity against otherwise drug-resistan…

Models MolecularCell SurvivalStereochemistryBiochemistrychemistry.chemical_compoundSulfanilamideCell Line TumorSulfanilamidesDrug DiscoverymedicineHumansCytotoxic T cellDoxorubicinATP Binding Cassette Transporter Subfamily B Member 1Homology modelingCytotoxicityPharmacologyLeukemiaChemistryOrganic ChemistryResazurinSulfanilamidemedicine.diseaseProtein Structure TertiaryLeukemiaDoxorubicinDrug Resistance NeoplasmMolecular MedicineVerapamilmedicine.drugCurrent Medicinal Chemistry
researchProduct

Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind tri…

1982

A new combination of trimethoprim with a sulphonamide, named Kelfiprim, differs from cotrimoxazole in that: a) the sulpha drug is sulphamethopyrazine instead of sulphamethoxazole; b) the trimethoprim to sulpha ratio is 5:4 instead of 1:5;c) the presence of a long-acting sulphonamide allows the administration of a daily dose of one capsule, following an initial loading dose of two capsules; d) a reduced amount of trimethoprim is given, as compared to cotrimoxazole, without any decrease of efficacy. Kelfiprim [KP] was compared to contrimoxazole [Co] in a multicentre double blind trial. Sixty four patients suffering from acute and chronic infections of the upper and lower urinary tract entered…

NephrologyMalemedicine.medical_specialtySulfamethoxazoleUrologyUrinary systemUrineGastroenterologyLoading doseTrimethoprimDouble blindDouble-Blind MethodInternal medicineSulfanilamidesTrimethoprim Sulfamethoxazole Drug CombinationmedicineHumansClinical Trials as Topicbusiness.industrySulfaleneTrimethoprimSurgeryDrug CombinationsUrinary Tract InfectionsFemalebusinessmedicine.drugUrological research
researchProduct

CCDC 140610: Experimental Crystal Structure Determination

2001

Related Article: E.Borras, G.Alzuet, J.Borras, J.Server-Carrio, A.Castineiras, M.Liu-Gonzalez, F.Sanz-Ruiz|2000|Polyhedron|19|1859|doi:10.1016/S0277-5387(00)00474-5

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinatesbis(4-Amino-N-(5-methyl-134-thiadiazole-3-yl-2-ylidene)sulfanilamide)-diaqua-bis(pyridine)-nickel(ii)
researchProduct

CCDC 140609: Experimental Crystal Structure Determination

2001

Related Article: E.Borras, G.Alzuet, J.Borras, J.Server-Carrio, A.Castineiras, M.Liu-Gonzalez, F.Sanz-Ruiz|2000|Polyhedron|19|1859|doi:10.1016/S0277-5387(00)00474-5

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(4-Amino-N-(5-methyl-134-thiadiazole-3-yl-2-ylidene)sulfanilamide)-diaqua-bis(pyridine)-cobalt(ii)Experimental 3D Coordinates
researchProduct

CCDC 140611: Experimental Crystal Structure Determination

2001

Related Article: E.Borras, G.Alzuet, J.Borras, J.Server-Carrio, A.Castineiras, M.Liu-Gonzalez, F.Sanz-Ruiz|2000|Polyhedron|19|1859|doi:10.1016/S0277-5387(00)00474-5

Space GroupCrystallographyCrystal SystemCrystal Structurecatena-(bis(mu~2~-4-Amino-N-(5-methyl-134-thiadiazole-2-ylidene)sulfanilamide)-bis(formamide)copper(ii))Cell ParametersExperimental 3D Coordinates
researchProduct

CCDC 140608: Experimental Crystal Structure Determination

2001

Related Article: E.Borras, G.Alzuet, J.Borras, J.Server-Carrio, A.Castineiras, M.Liu-Gonzalez, F.Sanz-Ruiz|2000|Polyhedron|19|1859|doi:10.1016/S0277-5387(00)00474-5

Space GroupCrystallographybis(4-Amino-N-(5-methyl-134-thiadiazole-2-yl-5-ylidene)sulfanilamide)-aqua-bis(pyridine)-copper(ii) monohydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct